Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Acute Myocardial Infarction
Netherlands
Sponsor: AstraZeneca
Heart Failure
Japan
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease
Germany
Sponsor: AstraZeneca
Asthma
China, Philippines, South Korea
Sponsor: Yale University
Heart Failure With Reduced Ejection Fraction
United States
Sponsor: AstraZeneca
Advanced Solid Malignancy · Safety and Tolerability · Pharmacokinetics · Pharmacodynamics
United States, Canada, Denmark, France, Italy +5 more
Sponsor: AstraZeneca
COVID-19
United Arab Emirates
Sponsor: AstraZeneca
COVID-19 · SARS-CoV-2 Infection
United States
- Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell CarcinomaCompleted
Sponsor: University of Colorado, Denver
Squamous Cell Carcinoma of the Head and Neck
United States
- LTFU for All Cell and Gene Therapy StudiesNot Yet Recruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma · Prostate Cancer
United States, Australia, Japan, South Korea
Sponsor: Daiichi Sankyo
Breast Cancer
United States, Belgium, Canada, France, Italy +4 more
Sponsor: AstraZeneca
Small Cell Lung Carcinoma
Italy
Sponsor: AstraZeneca
Solid Tumors
United States, France
- The DAPA-MEMRI TrialRecruiting
Sponsor: University of Edinburgh
Heart Failure · Diabetic Cardiomyopathies
United Kingdom
- HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: Daiichi Sankyo
Non-Small Cell Lung Cancer (NSCLC)
United States, Japan, South Korea, Taiwan
Sponsor: AstraZeneca
Hyperkalemia
United States, Argentina, Austria, Brazil, Bulgaria +21 more
Sponsor: AstraZeneca
Healthy
United Kingdom
- Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or LeukemiaActive Not Recruiting
Sponsor: Montreal Heart Institute
Breast Cancer · Lymphoma · Leukemia
Canada
- Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesTerminated
Sponsor: AstraZeneca
Haematological Malignancies
United States, Australia, France, Germany, Italy +1 more
Sponsor: University of Manitoba
Pediatric Readiness
Canada
- Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World SettingCompleted
Sponsor: AstraZeneca
Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE
China
Sponsor: AstraZeneca
Cardiovascular Diseases
United Kingdom
- A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerActive Not Recruiting
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Argentina, Austria, Belgium, Brazil +23 more
Sponsor: M.D. Anderson Cancer Center
Platinum-Resistant Fallopian Tube Carcinoma · Platinum-Resistant Ovarian Carcinoma · Platinum-Resistant Primary Peritoneal Carcinoma · Recurrent Fallopian Tube Carcinoma
United States
- Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialActive Not Recruiting
Sponsor: Royal Marsden NHS Foundation Trust
Adenocarcinoma of the Oesophagus · Adenocarcinoma of the Gastro-oesophageal Junction · Adenocarcinoma of the Stomach
United Kingdom